Pouncey Anna Louise, Woodward Mark
Department of Vascular Surgery, Division of Surgery and Cancer, Faculty of Medicine, Imperial College London, QEQM, St Mary's Hospital, Praed Street, London W2 1NY, UK.
The George Institute for Global Health, School of Public Health, Imperial College London, London W12 0BZ, UK.
Diagnostics (Basel). 2022 Mar 25;12(4):808. doi: 10.3390/diagnostics12040808.
Cardiovascular disease (CVD) is the leading cause of mortality in women worldwide but has been primarily recognised as a man's disease. The major components of CVD are ischaemic heart disease (IHD), stroke and peripheral arterial disease (PAD). Compared with IHD or stroke, individuals with PAD are at significantly greater risk of major cardiovascular events. Despite this, they are less likely to receive preventative treatment than those with IHD. Women are at least as affected by PAD as men, but major sex-specific knowledge gaps exist in the understanding of relevant CVD risk factors and efficacy of treatment. This prompted the American Heart Association to issue a "call to action" for PAD in women, in 2012. Despite this, PAD and CVD risk in women continues to be under-recognised, leading to a loss of opportunity to moderate and prevent CVD morbidity. This review outlines current evidence regarding cardiovascular risk in women and men with PAD, the relative significance of traditional and non-traditional risk factors and sex differences in cardiovascular risk management.
心血管疾病(CVD)是全球女性死亡的主要原因,但一直主要被视为男性疾病。CVD的主要组成部分是缺血性心脏病(IHD)、中风和外周动脉疾病(PAD)。与IHD或中风相比,PAD患者发生主要心血管事件的风险显著更高。尽管如此,与IHD患者相比,他们接受预防性治疗的可能性更小。女性受PAD的影响至少与男性一样,但在对相关CVD危险因素的理解和治疗效果方面存在重大的性别特异性知识差距。这促使美国心脏协会在2012年发布了针对女性PAD的“行动呼吁”。尽管如此,女性的PAD和CVD风险仍然未得到充分认识,导致错失减轻和预防CVD发病的机会。本综述概述了有关患有PAD的女性和男性心血管风险的现有证据、传统和非传统危险因素的相对重要性以及心血管风险管理中的性别差异。